HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/3/C445    most recent 00505.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Kidane, T. Z. Articles by Linder, M. C. Search for Related Content PubMed PubMed Citation Articles by Kidane, T. Z. Articles by Linder, M. C.

CELLULAR METABOLISM

Release of iron from ferritin requires lysosomal activity

Department of Chemistry and Biochemistry and Institute for Molecular Biology and Nutrition, California State University, Fullerton, California

Submitted 9 October 2005 ; accepted in final form 25 March 2006

How ferritin-Fe becomes available for cell functions is unknown. Our previous studies with rat hepatoma cells indicated ferritin had to be degraded to release its Fe. In these studies, we investigated whether this occurs in other cell types and whether lysosomes are required. Release of ferritin-Fe was induced with desferoxamine (DFO) in ⁵⁹Fe-preloaded hepatoma, Caco2, and erythroid K562 cells and measured by rocket immunoelectrophoresis and autoradiography. The half-lives for ferritin-⁵⁹Fe and protein were parallel (23, 16, and 11 h for the hepatic, Caco2, and K562 cells, respectively). Co-treatment with 180 µM Fe, leupeptin, chymostatin, or chloroquine markedly decreased rates of ferritin-Fe release and ferritin degradation. Lactacystin had no effect except for a small one in erythroid cells. Fractionation of hepatoma cell lysates on iodixanol gradients showed rapid depletion of cytosolic ferritin by DFO treatment but no accumulation in lysosomes. We conclude that regardless of cell type, release of Fe from ferritin occurs mainly through lysosomal proteolysis.

degradation; proteasomes

This article has been cited by other articles:

				E. C. Theil Mining ferritin iron: 2 pathways Blood, November 12, 2009; 114(20): 4325 - 4326. [Full Text] [PDF]

				I. De Domenico, D. M. Ward, and J. Kaplan Specific iron chelators determine the route of ferritin degradation Blood, November 12, 2009; 114(20): 4546 - 4551. [Abstract] [Full Text] [PDF]

				H. L. Persson and L. K. Vainikka Lysosomal iron in pulmonary alveolar proteinosis: a case report Eur. Respir. J., March 1, 2009; 33(3): 673 - 679. [Abstract] [Full Text] [PDF]

				W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826. [Abstract] [Full Text] [PDF]

				D. Zhang, E. Meyron-Holtz, and T. A. Rouault Renal Iron Metabolism: Transferrin Iron Delivery and the Role of Iron Regulatory Proteins J. Am. Soc. Nephrol., February 1, 2007; 18(2): 401 - 406. [Full Text] [PDF]